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Abstract
Objective—Despite guidelines recommending cervical cancer screening intervals be extended 
beyond one year, clinical practice has been slow to change. Patient preferences are a potential 
barrier. In the Centers for Disease Control's Cervical Cancer (Cx3) Study at Federally Qualified 
Health Centers (FQHCs) across Illinois, we surveyed patients about screening practices, and 
assessed beliefs regarding lengthening screening intervals.
Method—We analyzed data from 984 low income women in the Cx3 Study (2009–2011). 
Participants completed a survey assessing health history, knowledge about Pap testing, beliefs and 
intentions about extending screening intervals, and demographics.
Results—The majority reported annual Pap testing (61%), while only 24% reported a 2–3 year 
screening interval (recommendation at time of survey). Misunderstandings about the Pap test were 
prevalent, with over half believing it screened for vaginal, yeast, and sexually transmitted 
infections (58%–72%). Unfavorable beliefs about extending screening intervals were common. 
The majority (57%) indicated that they would not wait 3 years to be screened if their physician 
recommended it, and intentions were associated with knowledge about Pap testing.
Conclusion—Most women reported annual cervical cancer screening, and intended to resist 
longer screening intervals. Patients' lack of knowledge and unfavorable beliefs may serve as 
barriers to extending screening intervals. Published by Elsevier Inc.
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Current guidelines from U.S. professional medical organizations recommend that women 
who have a cervix and are at average risk of cervical cancer forego an annual Pap testing 
schedule in favor of extending the interval between routine screening tests. Specifically, the 
American College of Obstetricians and Gynecologists (ACOG), the United States Preventive 
Services Task Force (USPSTF), and the American Cancer Society (ACS) recommend that 
average risk women 30 to 65 years old be screened for cervical cancer via co-testing (i.e., 
Pap and HPV testing) every 5 years, or with Pap alone every 3 years (ACOG, 2012; Moyer, 
2012; Saslow et al., 2012). The current guidelines updated those issued in 2002/2003, which 
recommended extending intervals to 2–3 years for women 30 years and older with 3 
consecutive normal Pap test results (ACOG, 2003; USPSTF, 2003; Saslow et al., 2002). 
Despite the length of time passed since extended intervals were recommended and evidence 
supporting the safety of recommendations, clinical practice has been slow to change 
(Meissner et al., 2010; Roland et al., 2011; Saint et al., 2005; Saraiya et al., 2010; Sirovich 
and Welch, 2004; Yabroff et al., 2009). Five or more years after extended intervals were 
recommended, many medical providers continued to recommend annual screening (Benard 
et al., 2011; Meissner et al., 2010; Roland et al., 2011; Saraiya et al., 2010) and a recent 
survey of women confirmed the predominance of annual testing (Chen et al., 2012).
Patients' unfavorable attitudes about lengthening intervals have been recognized as a 
potential barrier to implementing current guidelines (MacLaughlin et al., 2011; Meissner et 
al., 2010; Sirovich and Welch, 2004; Sirovich et al., 2005). While some have found that 
patients are suspicious of motivations behind the guidelines (Sirovich et al., 2005), the wider 
variety of reasons behind patient resistance have not been fully explored.
As part of the Centers for Disease Control's Cervical Cancer (Cx3) Study, we surveyed a 
sample of women being screened for cervical cancer at Federally Qualified Health Centers 
(FQHC) on their knowledge about the Pap test, beliefs about extending screening intervals, 
and intentions to extend screening intervals.
Methods
Participants
Data were obtained from baseline surveys conducted October 2009 to May 2011 as part of 
Cx3, a study to identify barriers to appropriate cervical cancer screening practices and to 
implement an educational intervention to promote evidence-based screening practices. The 
study was conducted in 15 clinics associated with six FQHCs serving low income women in 
Illinois. FQHCs provide comprehensive primary health care services to medically 
underserved communities and vulnerable populations in high-need areas across the United 
States. A baseline survey was completed by a convenience sample of 984 women 30 to 60 
years old who were undergoing a regular screening Pap test (i.e., no: abnormal Pap test in 
the last year, cervical cancer, HIV, hysterectomy, or other known risk factors). Eligible 
patients were identified through medical chart review by clinic staff and were invited to 
participate when they arrived at the clinic for their visit. No records were kept on those who 
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refused participation; thus, we could not calculate a response rate. Women were offered a $5 
cash incentive for participation. Baseline questionnaires were self-administered in the clinic 
waiting room prior to the woman's exam and were available in English and Spanish. They 
elicited information on demographic characteristics, cervical cancer screening history, risk 
factors, knowledge and beliefs about cervical cancer screening, and cost of health care 
services. The questionnaire was pilot tested with nine women at a FQHC clinic in Atlanta, 
Georgia. This study was approved by CDC's Institutional Review Board and informed 
consent was obtained from study participants.
Measures
Knowledge about the purpose of the Pap test was assessed by questions modified from 
previously published research (Hawkins et al., 2011). Questions asked, “Do you agree or 
disagree that the Pap test is used to check for…” Nine conditions were listed with the 
following response options: “Agree,” “Disagree,” and “Not Sure” (see Fig. 1 for the 
conditions). Women (n = 26) who did not answer any of the nine items but answered other 
questions on the same and subsequent pages of the survey were categorized as answering 
“Not Sure” to all conditions. Those who did not answer any items nor adjacent questions (n 
= 22) were categorized as having missing responses.
Knowledge about the purpose of the Pap test was summarized in two ways. First, as shown 
in Fig. 1, participants were categorized by believing the Pap test screens for: (a) cervical 
cancer exclusively, (b) other conditions exclusively, or (c) cervical cancer plus other 
conditions. Second, a score was created to represent participants' "general Pap 
understanding," which prioritized knowing that the Pap test screens for cervical cancer and 
ignored beliefs about the Pap test's link with two conditions: HPV and vaginal cancer. 
Beliefs about HPV and vaginal cancer were excluded from this score because of HPV's 
close connection with cervical cancer and because in rare circumstances it is clinically 
advisable to use a Pap test to detect vaginal cancer. Participants who did not check cervical 
cancer were categorized as having poor general Pap understanding. Participants who 
checked cervical cancer but also checked pregnancy, HIV, gonorrhea, chlamydia, yeast 
infections and/or vaginal infections were also categorized as having poor general Pap 
understanding. Participants who checked cervical cancer and no additional conditions 
(excluding HPV and vaginal cancer) were considered to have good general Pap 
understanding.
Seven items developed for this study elicited participants' beliefs about waiting three years 
between Pap tests. This series of questions began with the introductory language, “Waiting 
three years for my next Pap test …” and followed with seven beliefs (displayed in Fig. 2). 
The specific beliefs assessed by these items were based on previous research (e.g., Sirovich 
et al., 2005). Participants were instructed to indicate whether they agreed, disagreed or 
neither agreed nor disagreed with each statement.
Intention to wait three years between Pap tests was assessed by a question developed for this 
study: “If your health care provider recommends that you have your next Pap test in 3 years, 
how likely are you to wait that long?” Five response options from“Very unlikely” to “Very 
likely” with a “Neither”/“Not sure” midpoint were offered.
Hawkins et al. Page 3














We present descriptive statistics for all measures. Analyses of beliefs and intentions to wait 
three years between Pap screenings were conducted on a subset of respondents (n = 663), as 
skip patterns in the survey necessitated excluding those who had never heard of HPV (n = 
194) and who were above average risk for cervical cancer based on the following: they were 
told to return in less than a year based on their last Pap test results (n = 61); they had tested 
positive for HPV (n = 8); or, they had an abnormal Pap test result in the previous three years 
(n = 51).
Ordered logit regression was conducted to examine the association between general Pap 
understanding and intentions to follow a three-year screening interval (outcome variable). 
The ordered logit model assumes the proportionality of the odds-ratio. The proportionality 
assumption was tested with the Brant test; no violation was found (chi-square = 1.37 with 
d.f. = 3, p = .7412). Stata release 12.1 was used to fit the ordered logit models using 
maximum likelihood estimation. Estimation of standard errors accounted for the clinic-based 
clustered sampling design using the Stata survey (svyset) option. The significance level was 
set as two-sided p = 0.05.
Results
Demographic characteristics for the whole sample and subsample are presented in Table 1. 
Study participants were females between the ages of 30 and 60 (mean 45 years; standard 
deviation [SD] 7.5), 32% Hispanic, 39% non-Hispanic white, and 26% non-Hispanic black. 
Educational attainment was varied, with 32% not having completed a high school diploma, 
23% with a high school diploma, and 45% having attempted or completed degrees in higher 
education. Only 21% held private insurance while 45% had no insurance, and 40% had 
public or another type of coverage (percentages add to >100% because respondents could 
check more than one category of insurance).
As Table 1 shows, the majority reported receiving annual Pap tests (61%) and were advised 
to return annually (66%) after their last Pap test. While 28% reported ever having an 
abnormal Pap test result, the average time since most recent abnormal test was 9.8 (SD 7.8) 
years (not in table).
When asked about conditions for which the Pap test checks, respondents selected “agree” to 
a mean of 5.6 (SD 2.9) conditions out of nine. As Fig. 1 shows, cervical cancer was most 
commonly selected (87%). Only 5% indicated that cervical cancer was the only condition 
detected by the Pap, while 82% believed the Pap test screened for cervical cancer in 
conjunction with one or more conditions on the list. Over half believed that the Pap test 
screened for chlamydia (58%), gonorrhea (59%), yeast infections (65%), HPV virus (71%), 
vaginal infections (72%) and vaginal cancer (79%). A sizable minority believed that it 
checked for HIV/AIDS (40%) and pregnancy (33%).
Categorizing participants by their “general Pap understanding” using the definition above, 
revealed that 15% had a good general understanding of the Pap test's purpose (i.e., knew it 
checked for cervical cancer and did not believe it checked for chlamydia, gonorrhea, yeast 
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or vaginal infections), while 85% had a poor general understanding. Of those with a poor 
general understanding, 15% did not recognize that it checked for cervical cancer while 85% 
knew that it checked for cervical cancer but also believed it checked for one or more of the 
other conditions (data not shown).
Beliefs about lengthening screening intervals to 3 years can be seen in Fig. 2. The majority 
believed longer intervals would cause them to worry about getting cancer (68%), and half 
(50%) believed they would increase their chances of getting cancer. While 38% agreed with 
the statement that waiting 3 years “is something your doctor thinks you should do,” 34% 
disagreed. Just over one third (36%) believed that waiting 3 years would prevent them from 
getting other needed health care, and one-third or fewer agreed that waiting longer between 
Pap tests would save time (33%), money (31%), or give peace of mind (30%).
When asked how likely they would be to follow a health care provider's recommendation to 
wait 3 years until their next Pap test, 22% said “very likely,” 13% said “somewhat likely,” 
8% said “neither unlikely nor likely/not sure,” 14% said “somewhat unlikely,” and 43% said 
“very unlikely” (data not shown).
Fig. 3 shows intentions to wait 3 years between Pap tests by general Pap understanding. Of 
women with poor general understanding, 45% reported that they were very unlikely to wait 
3 years compared to 31% of women with a good general understanding. When tested with 
ordinal regression, women with a good general understanding of the Pap test were more 
likely to report a more favorable intention to wait 3 years for their next Pap test than women 
with poor understanding (O.R. = 1.66, 95% confidence interval 1.11–2.51).
Discussion
In this sample of low-income women at Federally Qualified Health Centers across Illinois, 
annual Pap testing was the norm and very few reported screening intervals consistent with 
newer recommendations for women at average risk of cervical cancer. Only 11% reported 
previously receiving guidance from their providers to return for a routine Pap test in two or 
three years, as had been the recommendation in place for over five years. This finding is 
similar to other recent accounts (Meissner et al., 2010; Roland et al., 2011; Saraiya et al., 
2010) and suggests that over-screening persists, even among the under- and un-insured.
Given that the majority reported being told after their last Pap test to return for their next test 
in 1 year, perhaps it is not surprising that over half said they would be unlikely to wait 3 
years between Pap tests if their physician recommended it. Physician recommendation is an 
important influence on patient behavior and the recommendation actually received by most 
of the women in our study had been to undergo annual Pap testing. Without widespread 
change in the intervals physicians recommend to their patients, significant change in Pap 
testing practices will be unlikely. For this reason, multi-pronged approaches to educate both 
providers and patients about evidence-based guidelines for screening and to encourage 
guideline-consistent practices at the provider level are essential.
In our search for patient-related barriers to recommended screening practices, we looked to 
knowledge, beliefs and intentions regarding Pap testing and found that many women 
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displayed poor understanding of the purpose of the Pap test. While the vast majority 
recognized that Pap tests are used to screen for cervical cancer, substantial proportions also 
believed that they are used to check for many other conditions, including pregnancy, HIV/
AIDS, and chlamydia. These findings are consistent with previous work showing 
misconceptions about Pap testing among the general population (Hawkins et al., 2011), and 
suggest that patient education is needed to improve understanding of this widely used 
screening test. Misunderstandings about the purpose of Pap tests could indicate inadequate 
patient–provider communication about this test and about the bundling of tests that 
sometimes occurs with the Pap test. For example, providers may choose to test for sexually 
transmitted infections at the same time they administer a Pap test. If patients are not told that 
multiple tests are being conducted from the sample taken at the time of the Pap test, any 
subsequent diagnoses may be misunderstood by the patient to have been detected by the Pap 
test, thus leading to misunderstandings about the purpose of the Pap test.
We found that misunderstandings could also present a barrier to extending Pap test 
screening intervals. While over half of the women said they would be unlikely to follow a 
doctor's recommendation to wait 3 years between Pap tests, intentions were associated with 
the general understanding about the Pap test's purpose. Women with the poorest 
understanding were significantly more likely than those with better understanding to indicate 
that they would not wait 3 years between tests. Although we did not directly ask women 
why they would not favor interval extension, it is possible that the more conditions a woman 
believes are revealed by a Pap test, the more essential she may believe the test to be in terms 
of gauging overall gynecological health. Thus, women who believe the Pap test screens only 
for cervical cancer may be more comfortable with waiting longer between tests than women 
who believe the Pap test screens for multiple gynecological cancers, sexually transmitted 
infections, and pregnancy. As efforts are made to encourage guideline-consistent cervical 
cancer screening practices, it may be useful to develop educational materials that present 
information about the safety of less frequent screening, while explaining the purpose of Pap 
testing as it differs from other types of testing that may or may not be offered in conjunction 
with it.
We identified a number of beliefs that may serve as barriers to extending Pap testing 
intervals. Among the most common was that waiting longer between tests would put women 
at higher risk of cervical cancer, and increase worry about getting cervical cancer. Beliefs of 
this nature indicate a need for patient education on the rationale behind extending the 
screening interval beyond one year. Educational efforts should explain the potential harms 
involved in screening more often than clinically advised (Moyer, 2012) and directly address 
the common misconception that the decision to extend screening intervals is primarily 
financially driven (Sirovich et al., 2005). The majority of women in our study did not 
believe waiting longer between Pap tests would present benefits such as saving time, cost, 
and promoting peace of mind. Interestingly, only a minority of women believed waiting 
longer between tests would prevent them from getting other needed healthcare, a concern 
that is commonly expressed by medical care providers (Roland et al., 2013).
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Despite the strengths of this study in examining the knowledge, beliefs and intentions of 
medically underserved patients, several limitations should be noted. We did not include 
questions on all aspects of medical history (i.e., high-grade precancerous cervical lesions, in 
utero exposure to diethylstilbestrol, immunocompromised health status), which are known to 
contribute to cervical cancer risk and may indicate the need for more frequent screening. 
Instead, we relied upon clinic staff to review medical records in determining initial 
eligibility and specified that the study include only women seeking routine cervical 
screening. We excluded women who reported recent abnormal Pap tests, positive HPV test 
results and other screening-related problems.
Another limitation given the nature of the study methodology (i.e., self-administered survey) 
is that it was not possible to fully explore women's understanding of the Pap test. Response 
bias could have led women to answer affirmatively to the conditions presented, and inflate 
the number of conditions believed to be associated with the Pap test.
Conclusions
In summary, our findings suggest widespread misunderstandings among medically 
underserved women about the purpose of the Pap test and shed light on potential barriers to 
guideline-consistent screening behavior. As the Cx3 Study continues, it will be possible to 
determine whether efforts to educate both women and medical care providers on cervical 
cancer screening will result in changes to attitudes and actual screening behavior.
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Knowledge about the purpose of the Pap test in screening for cancer and othzer conditions 
(n = 962). (Study was conducted in 15 Federally Qualified Health Center clinics in Illinois, 
USA, 2009–2011.)
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Beliefs about waiting three years between Pap tests (n = 600–618). (Study was conducted in 
15 Federally Qualified Health Center clinics in Illinois, USA, 2009–2011.)
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Intentions to wait three years before the next Pap test by general understanding of the Pap 
test's purpose (n = 608). (Study was conducted in 15 Federally Qualified Health Center 
clinics in Illinois, USA, 2009–2011.)
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Table 1
Participant demographic characteristics, pap testing history, and gynecologic health history. Full study sample 
and subsample included in analyses of beliefs and intentions to wait 3 years. (Study was conducted in 15 





N % N %
Age
  Age at baseline, years (Mean ± SD) 45.0 ± 7.5 45.1± 7.6
Race — ethnicity
  Hispanic 312 32 200 30
  Non-Hispanic White 384 39 278 42
  Non-Hispanic Black, African American 254 26 162 25
  Non-Hispanic other/multiple races 26 3 17 3
Marital status
  Never married 176 18 121 18
  Unmarried, living with partner 80 8 56 9
  Married 430 44 286 44
  Separated/divorced 250 26 169 26
  Widowed 37 4 25 4
Highest level of schooling completed
  <High school diploma 300 32 189 29
  High school diploma or GED 217 23 133 21
  Some college or AA 296 31 215 34
  Bachelor's degree or higher 133 14 104 16
Type of insurance coverage (respondent could check all that apply)
  Private insurance 200 21 151 24
  Medicare 89 10 65 10
  Medicaid/medical coupons 159 17 105 16
  Military or veterans administration 5 1 3 <1
  Illinois BCCP 87 9 56 9
  No insurance 416 45 276 43
  Other insurance 30 3 20 3
Current employment status
  Employed or self-employed full- or part-time 472 54 329 55
  Unemployed 182 21 124 21
  Unable to work 60 7 39 7
  Homemaker 152 17 99 17
  Student/retired 11 1 6 1
Pap test history
  How many Pap tests in lifetime?
    Never 6 1 3 <1


















N % N %
    1 time 14 2 6 1
    2–4 times 125 13 81 13
    5–10 times 279 29 187 29
    >10 times 527 55 370 57
  How often get Pap tests?
    More often than once a year 22 2 8 1
    Once a year 561 61 387 62
    Once every 2–3 years 223 24 156 25
    Less often than once every 3 years 114 12 74 12
    Today is first 6 1 3 <1
  After last Pap test, when told to return for next one?
    As soon as possible 19 2 0 0
    6 months 55 6 0 0
    1 year 600 66 442 71
    2 years 82 9 63 10
    3 years 14 2 12 2
    No one said/not sure 145 16 102 16
  Abnormal Pap test results, everb
    Yes 266 28 145 23
    No 639 69 466 74
    Not sure 29 3 18 3
Gynecologic health history
  HPV infection, everc
    Yes 47 5 26 4
    No 825 92 566 92
    Not sure 23 3 20 3
  Sexually transmitted infection(s), ever
    Yes 198 21 128 20
    No 714 77 487 77
    Not sure 22 2 14 2
  Genital warts, ever
    Yes 82 9 57 9
    No 848 90 572 90
    Not sure 14 1 8 1
a
The subsample used in analyses of beliefs and intention to wait three years between Pap screenings excluded women who had never heard of HPV 
(as necessitated by a skip pattern) or who were considered above average risk for cervical cancer.
b
Respondents who were having their first Pap test were recoded as never having an abnormal Pap result.
c
Respondents who had never heard of HPV were recoded as never having been diagnosed with an HPV infection.
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